Networking Startup Veteran Joins OpsMill as Board Advisor
OpsMill, a pioneer in infrastructure and network automation, today announced that Justin Biegel has joined the company’s Board of Directors as a Board Advisor. Biegel is COO and co-Founder of Kentik, a network observability leader. He will leverage his experience working in network automation, leading GTM efforts, and scaling startups to assist OpsMill strategically as it looks to execute its unique approach to infrastructure and network automation.
“OpsMill is led by a pair of smart founders that have created a groundbreaking solution to the hard problems infrastructure and networking professionals face. Infrahub is an innovative approach to network data management that enables network teams to easily modernize their infrastructure management efforts,” said Justin Biegel, Board Advisor, OpsMill. “They’re coming at just the right time: Network automation is taking off faster than a rocket ship. While we’re still in the early days for network source of truth systems like Infrahub, these systems will prove that they’re a requirement for enterprises to unlock the full potential of network automation. I’m thrilled for the opportunity to work with Damien, Raphael, and the rest of the OpsMill team in a space that I know well from my time founding and building Kentik.”
Biegel brings demonstrated GTM and operational leadership to the role. He has over 10 years of experience working in technology sales and scaling infrastructure and networking companies. During that time, he helped grow Kentik from the ground up as the first head of sales, while serving a diverse roster of customers and broad range of industries across the world.
“Justin brings such value to us as founders as we rapidly grow our company,” said Damien Garros, CEO and co-Founder, OpsMill. “His sales, GTM, and operations background complements our deep technical expertise, forging a partnership that’ll ensure OpsMill maximizes our market reach.”
Biegel co-founded Kentik in 2014 and became COO in 2021. The company has raised $102 million through its series C round of funding. Tech giants Zoom, Box, and Dropbox all use the technology to achieve complete hybrid and multi-cloud network observability.
Before co-founding Kentik, Biegel was responsible for sales in Northern California and the Pacific Northwest at Internap, a global provider of performance-driven, secure hybrid infrastructure solutions, where he led his regions to record-breaking performance. Biegel graduated with honors from DePaul University with a BA in Economics.
“Justin is a perfect addition to our advisory bench,” said Raphael Maunier, COO and co-Founder, OpsMill. “He’s worked across the infrastructure and networking spaces. Specifically, his career has taught him the increasing importance – and challenge – of network automation today.”
The move underscores OpsMill’s continuing efforts to enhance its Board of Directors with proven networking leaders.
About OpsMill
OpsMill is the infrastructure automation platform company, bringing the best practices and features of the industry’s leading automation approaches together in a single, scalable, and extensible platform so that infrastructure, cloud, network, and security teams can focus on innovation rather than integrating toolsets. Infrahub by OpsMill is the industry’s leading open-source integrated infrastructure automation platform. OpsMill is backed by Serena Capital, Partech, OVNI Capital, Kima Ventures and Better Angle. For more information, visit OpsMill.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240813268658/en/
Contacts
Jordan Tewell
10Fold for OpsMill
opsmill@10fold.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zambon Announces Publication of Phase 3 PROMIS I and II Study Results in The Lancet Respiratory Medicine Showing Efficacy Results of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis Colonized with P. aeruginosa13.9.2024 12:00:00 EEST | Press release
Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people’s health and the quality of patients’ lives, today announced the online publication of its Phase 3 PROMIS-I and PROMIS-II studies in The Lancet Respiratory Medicinejournal. The PROMIS studies assessed the efficacy and safety of inhaled colistimethate sodium administered via the I-neb® Adaptive Aerosol Delivery System (“CMS I-neb”) as a treatment to reduce the frequency of pulmonary exacerbations in patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) chronically colonized with P. aeruginosa over 12 months, compared to placebo. “The publication of these pivotal data in The Lancet Respiratory Medicine represents an important milestone in our commitment to developing innovative therapies for patients with severe respiratory diseases,” said Paola Castellani, Chief Medical Officer and R&D Head at Zambon. “For patients with NCFB, a condition with no approved treatment options, the results
Intelsat Signs Hybrid Media Deal Distributing Hearst Networks EMEA Content13.9.2024 10:00:00 EEST | Press release
Intelsat, operator of one of the world’s largest integrated satellite and terrestrial networks, successfully launched a hybrid television content distribution service to deliver Hearst Networks EMEA (formerly known as A+E Networks EMEA) channels to hundreds of points across Europe thanks to its seamless satellite-terrestrial connection. “Growing global media customers like Hearst Networks EMEA want to work with a single operator that can provide seamless connections from satellite to ground-based Internet Protocol distribution networks,” said Rhys Morgan, regional vice president, EMEA, Media and Networks. “Intelsat has visibility across the full distribution network, even when it spans multiple technologies and can enable customers to reach more end users.” In order to reach a wide group of viewers, content providers typically use multiple distribution mediums such as direct-to-home (DTH), cable and IPTV. Hearst Networks EMEA needed to maximize the reach of its flagship channels, The H
NATO Support and Procurement Agency Contracts SES’s O3b mPOWER for Secure Communications Services13.9.2024 09:30:00 EEST | Press release
The NATO Support and Procurement Agency (NSPA) has awarded SES a contract to deliver secure high-performance low-latency satellite services via its medium earth orbit (MEO) constellation, enabling global missions for NATO member government organisations, agencies and military. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910404747/en/ NATO Support and Procurement Agency Contracts SES’s O3b mPOWER for Secure Communications Services (Photo: Business Wire) The MEO Global Services (MGS) award represents a three-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at USD 200M, with two one-year options. This is the first award under the Global Commercially Contracted Satellite Communications Support Partnership (GCC SATCOM SP) established by the U.S. and Luxembourg under the auspices of NSPA in 2022, opening a new era of space cooperation within NATO. The MGS will be available to all NATO countries, including
SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S.13.9.2024 09:00:00 EEST | Press release
SamanTree Medical, a leader in innovative surgical imaging solutions, today announced that it has received FDA 510(k) clearance of its Histolog® Scanner for imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture. This groundbreaking Swiss made device is designed to provide real-time, highresolution imaging of fresh tissue surfaces, offering surgeons and pathologists this information for excised tissue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240912995435/en/ The Histolog Scanner in use for rapid visualization of fresh tissue microstructures. (Photo: SamanTree Medical) The Histolog® Scanner enables real-time, ultra-fast confocal microscopy, allowing for the immediate imaging of resected tissues. This advancement aims to enable physicians to improve their efficiency. “We are thrilled to introduce the Histolog® Scanner t
Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types13.9.2024 09:00:00 EEST | Press release
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data from several studies utilizing Guardant technology to advance precision oncology at the European Society for Medical Oncology Congress (ESMO) in Barcelona, Spain, Sept. 13-17, 2024. Data on the Guardant Reveal™ minimal residual disease test in locally advanced rectal cancer patients enrolled in the NO-CUT trial will be presented in a proffered paper session during Presidential Symposium III. Other presentations will include findings from studies evaluating Guardant360® for therapy selection in advanced breast cancer and other solid tumors, and the Guardant Infinity™ platform for response monitoring in advanced non-small cell lung cancer (NSCLC). “Our latest data featured at ESMO further highlight the value of Guardant’s technology in precision oncology and the critical role liquid biopsy can play in informing therapy selection and treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom